mavorixafor

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

XOLREMDI — X4 PHARMS, approved 2024-04-26 (NDA218709).

Most reported adverse events (US / FAERS)

18 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

product administration error

3

product storage error

2

arthralgia

1

bone pain

1

Medicines containing this active substance

1 medicines

Xolremdi

Authorised

🇺🇸 Also approved in the US (FDA)

XOLREMDI — X4 PHARMS, approved 2024-04-26 (NDA218709).

Most reported adverse events (US / FAERS)

18 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

product administration error

3

product storage error

2

arthralgia

1

bone pain

1

covid-19

1

feeling jittery

1

gastrointestinal disorder

1

hallucination

1

influenza

1

nausea

1

neutrophil count increased

1

pain

1

pneumonia bacterial

1

pyrexia

1

urinary incontinence

1